The 5% Problem: The Access Gap Behind GLP-1s, Hormone Therapy, and Midlife Weight Gain What the science actually shows about menopause, metabolism, and GLP-1s - and why the biggest barrier isnt biology, but access to evidence-based care
They are able to enter the mitochondria via facilitative glucose transporters and confer mitochondrial protection against oxidative injury as well, though at a much lower level
In the BPC-157 vs TB-500 comparison, BPC-157 is characterised as a local, angiogenesis-focused peptide most studied in tendon, ligament and gut tissue, while TB-500 is described as a systemic, cell-migration peptide studied across cardiac, neural and multi-tissue models
For the difference between water types, see bacteriostatic water vs sterile water